Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2026-01-03 @ 10:54 PM
Study NCT ID:
NCT06567457
Status:
WITHDRAWN
Last Update Posted:
2024-08-22
First Post:
2023-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Safety Study of Monovalent Omicron XBB.1.5 Vaccine as a Booster in Adults
Sponsor:
Clover Biopharmaceuticals AUS Pty
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-23
First Submit QC Date:
None
Study First Post Date:
2024-08-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-20
Last Update Post Date:
2024-08-22
Last Update Post Date Type:
ACTUAL